TrialJournal of the American Society of Nephrology : JASN2020

Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial.

Meg J Jardine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.